Dow Jones (DJIA) Today: Pfizer (PFE) Lower

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer..

The Dow Jones Industrial Average ( ^DJI) is trading up 61 points (+0.3%) at 18,071 as of Monday, Jun 1, 2015, 1:36 p.m. ET. During this time, 192.2 million shares of the 30 Dow components have changed hands vs. an average daily trading volume of 358.9 million. The NYSE advances/declines ratio sits at 1,892 issues advancing vs. 1,131 declining with 155 unchanged.
  • EXCLUSIVE OFFER: Jim Cramer's Protégé, Dave Peltier, only buys Stocks Under $10 that he thinks could potentially double. See what he's trading today with a 14-day FREE pass.

Holding back the Dow today is Pfizer (NYSE: PFE), which is lagging the broader index with a two-cent decline to $34.74. Volume for Pfizer currently sits at 17.9 million shares traded vs. an average daily trading volume of 25.8 million shares.

Pfizer has a market cap of $212.07 billion and is part of the health care sector and drugs industry. Shares are up 11.6% year-to-date as of Friday's close. The stock's dividend yield sits at 3.3%.

Pfizer Inc., a biopharmaceutical company, discovers, develops, manufactures, and sells healthcare products worldwide.

TheStreet Ratings rates Pfizer as a buy. The company's strengths can be seen in multiple areas, such as its solid stock price performance, largely solid financial position with reasonable debt levels by most measures, reasonable valuation levels, expanding profit margins and growth in earnings per share. We feel its strengths outweigh the fact that the company has had somewhat disappointing return on equity.

If you liked this article you might like

Dow, S&P 500 Set New Records as Fed Moves to Unwind Balance Sheet

Stocks In Negative Territory as Chances for December Hike Surge

The Wait for 'Milestone' Fed Meeting Keeps Stocks in Flux

The 6 Medications Being Used to Tackle the Opioid Epidemic